omniture
苏州蔚程医药有限公司

Latest News

Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development

* Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery techn...

2026-04-10 20:00 5545